Ai Mogi

Patient perceptions of symptoms and concerns during cancer chemotherapy: ‘affects my family’ is the most important

H. Sasaki, Kazuo Tamura, Yoshiko Naito et al. · International Journal of Clinical Oncology · 2017 · 43 citations · Full text

Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients

Yoichiro Yoshida, Seiichiro Hoshino, Naoya Aisu et al. · International Journal of Clinical Oncology · 2014 · 27 citations

Port-free Chemotherapy, Surgical Oncology, Medicine +6

5-Fluorouracil Chemotherapy for Dihydropyrimidine Dehydrogenase-deficient Patients: Potential of the Dose-escalation Method.

Yoichiro Yoshida, Kenichiro Ogura, Akira Hiratsuka et al. · PubMed · 2015 · 19 citations

Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma

Ai Mogi, Kaori Koga, Mikiko Aoki et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2012 · 18 citations

Malignant Pleural Mesothelioma, Malignant Disease, Pathology +4

Can grade 2 neutropenia predict the risk of grade 3 neutropenia in metastatic colorectal cancer patients treated with chemotherapy?

Yoichiro Yoshida, Seiichiro Hoshino, Naoya Aisu et al. · Supportive Care in Cancer · 2014 · 17 citations

Cancer Risk, Gastrointestinal Oncology, Medicine +7